CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
3 hedge funds and large institutions have $360K invested in Global X China Biotech Innovation ETF in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$190K |
Top Sellers
| 1 |
Jane Street
New York
|
-$33.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $190K | +$190K | +16,484 | New |
|
|
2
Jane Street
New York
| $167K | -$33.4K | -2,907 | -17% |
|
|
BBPWM
3
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $3K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$25K | -1,749 | Closed |
|